Tanta
Tanta
Tanta, Elgharbeya, Egypt2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardioprotection Effect of Linagliptin | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07852546 | |
| Cardioprotective Effect of Empagliflozin in Breast Cancer Patients | Empgliflozin Cardioprotective Effect | Not yet recruiting | Phase 3 | 2026-09-24 | NCT07815808 |